The rFGF21 administration given 6 h after stroke eliminated this reduction (263.8% increase in CD36 and 199.6% increase in FABP4) (Figure 3A), which reflected the change of cerebrovascular PPARγ activity. This evidence concerns the gene CD36 and stroke disorder.